Download PDF
Thromb Haemost 2008; 99(03): 632-633
DOI: 10.1160/TH08-01-0060
Letters to the Editor
Schattauer GmbH

Type 2B-like von Willebrand disease: A creative approach to a difficult diagnosis

Alessandra Casonato
1   Department of Medical and Surgical Sciences, Medical School, University of Padua, Padua, Italy
,
Francesca Sartorello
1   Department of Medical and Surgical Sciences, Medical School, University of Padua, Padua, Italy
,
Elena Pontara
1   Department of Medical and Surgical Sciences, Medical School, University of Padua, Padua, Italy
,
Lisa Gallinaro
1   Department of Medical and Surgical Sciences, Medical School, University of Padua, Padua, Italy
,
Maria Grazia Cattini
1   Department of Medical and Surgical Sciences, Medical School, University of Padua, Padua, Italy
› Author Affiliations
Further Information

Publication History

Received: 31 January 2008

Accepted after major revision: 04 February 2008

Publication Date:
07 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Casonato A, Sartorello F, Pontara E. et al. A novel von Willebrand factor mutation (I1372S) associated with type 2B-like von Willebrand disease: an elusive phenotype and a difficult diagnosis. Thromb Haemost 2007; 98: 1182-1187.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Casonato A, Pontara E, Bertomoro A. et al. Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity?. Brit J Haematol 2001; 112: 578-583.
    CrossrefPubMedGoogle Scholar
  • 3 Favaloro EJ, Bonar R, Meiring M. et al. ; on behalf of the RCPA QAP in Haematology. 2B or not 2B? Disparate discrimination of functional VWF discordance using different assay panels or methodologies may leadto success or failure in the early identification of type 2B VWD. Thromb Haemost 2007; 98: 346-358.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Quiroga T, Goyoolea M, Panes O. et al. High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. Prospective study of 280 patients and 299 controls. Haematologica 2007; 92: 292-296.
    CrossrefPubMedGoogle Scholar
  • 5 Casonato A, De Marco L, Mazzuccato M. et al. A new congenital platelet abnormality characterized by spontaneous platelet aggregation, enhanced von Willebrand factor platelet interaction and the presence of all von Willebrand factor multimers in plasma. Blood 1989; 74: 2028-2033.
    PubMedGoogle Scholar
  • 6 Nishio K, Anderson PJ, Zheng XL. et al. Binding of platelet glycoprotein Ib alpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS-13. Proc Natl Acad Sci USA 2004; 101: 10578-10583.
    CrossrefPubMedGoogle Scholar
  • 7 Rayes J, Hommais A, Legendre P. et al. Effect of von Willebrand disease type 2B and type 2M mutations on the susceptibility of von Willebrand factor to ADAMTS-13. J Thromb Haemost 2006; 5: 321-328.
    PubMedGoogle Scholar
  • 8 Casonato A, Steffan A, Pontara E. et al. Post- DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation. Thromb Haemost 1999; 81: 224-228.
    Article in Thieme ConnectPubMedGoogle Scholar